These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12776200)

  • 1. Effects of methylation on expression of TMS1/ASC in human breast cancer cells.
    Levine JJ; Stimson-Crider KM; Vertino PM
    Oncogene; 2003 May; 22(22):3475-88. PubMed ID: 12776200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.
    Conway KE; McConnell BB; Bowring CE; Donald CD; Warren ST; Vertino PM
    Cancer Res; 2000 Nov; 60(22):6236-42. PubMed ID: 11103776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
    Stimson KM; Vertino PM
    J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
    Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
    Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma.
    Stone AR; Bobo W; Brat DJ; Devi NS; Van Meir EG; Vertino PM
    Am J Pathol; 2004 Oct; 165(4):1151-61. PubMed ID: 15466382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
    Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
    Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma.
    Guan X; Sagara J; Yokoyama T; Koganehira Y; Oguchi M; Saida T; Taniguchi S
    Int J Cancer; 2003 Nov; 107(2):202-8. PubMed ID: 12949795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation status and expression of TMS1 gene in human epithelial ovarian cancer.
    Akahira J; Sugihashi Y; Ito K; Niikura H; Okamura K; Yaegashi N
    Cancer Sci; 2004 Jan; 95(1):40-3. PubMed ID: 14720325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hMOF-dependent histone H4 lysine 16 acetylation in the maintenance of TMS1/ASC gene activity.
    Kapoor-Vazirani P; Kagey JD; Powell DR; Vertino PM
    Cancer Res; 2008 Aug; 68(16):6810-21. PubMed ID: 18701507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual role of TMS1/ASC in death receptor signaling.
    Parsons MJ; Vertino PM
    Oncogene; 2006 Nov; 25(52):6948-58. PubMed ID: 16715133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of TMS1/ASC in ovarian cancer.
    Terasawa K; Sagae S; Toyota M; Tsukada K; Ogi K; Satoh A; Mita H; Imai K; Tokino T; Kudo R
    Clin Cancer Res; 2004 Mar; 10(6):2000-6. PubMed ID: 15041718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-sensitive regulation of TMS1/ASC by the Ets factor, GA-binding protein-alpha.
    Lucas ME; Crider KS; Powell DR; Kapoor-Vazirani P; Vertino PM
    J Biol Chem; 2009 May; 284(22):14698-709. PubMed ID: 19324871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.
    Riojas MA; Guo M; Glöckner SC; Machida EO; Baylin SB; Ahuja N
    Cancer Biol Ther; 2007 Nov; 6(11):1710-6. PubMed ID: 17986858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proapoptotic caspase recruitment domain protein gene, TMS1, is hypermethylated in human breast and gastric cancers.
    Moriai R; Tsuji N; Kobayashi D; Yagihashi A; Namiki Y; Takahashi H; Watanabe N
    Anticancer Res; 2002; 22(6C):4163-8. PubMed ID: 12553049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG island methylation of TMS1/ASC and CASP8 genes in cervical cancer.
    Kordi Tamandani DM; Sobti RC; Shekari M; Huria A
    Eur J Med Res; 2009; 14(2):71-5. PubMed ID: 19258216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.